Medications for Carbamoyl Phosphate Synthetase 1 Deficiency
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Carbamoyl Phosphate Synthetase 1 Deficiency.
Found 1 Approved Drug for Carbamoyl Phosphate Synthetase 1 Deficiency
Phenylbutyrate
Brand Names
Olpruva, Buphenyl, Ravicti, Pheburane
Phenylbutyrate
Brand Names
Olpruva, Buphenyl, Ravicti, Pheburane
Form: Pellet, Tablet, Kit, Powder, Liquid
Method of administration: Oral
FDA approval date: April 30, 1996
Classification: Nitrogen Binding Agent
OLPRUVA is indicated as adjunctive therapy to standard of care, which includes dietary management, for the chronic management of adult and pediatric patients weighing 20 kg or greater and with a body surface area (BSA) of.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances